The Complex Landscape of Generic Drugs

This chapter explores the intricate dynamics of the pharmaceutical market, particularly focusing on the challenges faced by generic drug manufacturers after patent expirations. It examines the historical context, pivotal legislative agreements like the Hatch-Waxman Act, and the balancing act between fostering innovation and achieving lower prices for consumers. Despite initial successes in reducing drug costs, the chapter also highlights the pressing issues of market competition, quality, and the emergence of drug shortages.